Comments
Loading...

Gilead Sciences

GILDNASDAQ
Logo brought to you by Benzinga Data
$83.89
0.841.01%
At Close: -
$84.09
0.20.24%
After Hours: 6:00 PM EDT
15 minutes delayed
The dividend Ex-Date was 5 days ago
Consensus Rating1
Buy
Highest Price Target1
$112.00
Lowest Price Target1
$69.00
Consensus Price Target1
$84.42

Gilead Sciences (NASDAQ:GILD) Stock, Analyst Ratings, Price Targets, Forecasts

Gilead Sciences Inc has a consensus price target of $84.42 based on the ratings of 25 analysts. The high is $112 issued by Piper Sandler on February 3, 2023. The low is $69 issued by HSBC on April 24, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Piper Sandler, and Cantor Fitzgerald on September 16, 2024, September 11, 2024, and September 9, 2024, respectively. With an average price target of $78.33 between Cantor Fitzgerald, Piper Sandler, and Cantor Fitzgerald, there's an implied -6.85% downside for Gilead Sciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
3
Apr
1
Jun
1
1
Jul
1
1
Aug
1
2
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
Piper Sandler
RBC Capital
Truist Securities
BMO Capital

1calculated from analyst ratings

Analyst Ratings for Gilead Sciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Gilead Sciences (GILD) stock?

A

The latest price target for Gilead Sciences (NASDAQ:GILD) was reported by Cantor Fitzgerald on September 16, 2024. The analyst firm set a price target for $70.00 expecting GILD to fall to within 12 months (a possible -16.76% downside). 34 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Gilead Sciences (GILD)?

A

The latest analyst rating for Gilead Sciences (NASDAQ:GILD) was provided by Cantor Fitzgerald, and Gilead Sciences reiterated their neutral rating.

Q

When was the last upgrade for Gilead Sciences (GILD)?

A

The last upgrade for Gilead Sciences Inc happened on July 8, 2024 when Raymond James raised their price target to $93. Raymond James previously had a market perform for Gilead Sciences Inc.

Q

When was the last downgrade for Gilead Sciences (GILD)?

A

The last downgrade for Gilead Sciences Inc happened on February 22, 2024 when Truist Securities changed their price target from $91 to $82 for Gilead Sciences Inc.

Q

When is the next analyst rating going to be posted or updated for Gilead Sciences (GILD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gilead Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gilead Sciences was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.

Q

Is the Analyst Rating Gilead Sciences (GILD) correct?

A

While ratings are subjective and will change, the latest Gilead Sciences (GILD) rating was a reiterated with a price target of $70.00 to $70.00. The current price Gilead Sciences (GILD) is trading at is $84.09, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch